These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
127 related articles for article (PubMed ID: 22799028)
1. [Screening based on response surface methodology of multi-fractions traditional Chinese medicine with anti-influenza virus neuraminidase activity: take shuanghuanglian injection as an example]. Qiu LL; Chen LH; Yan D; Zhang P; Tan MR; Li ZM; Xiao XH Yao Xue Xue Bao; 2012 Apr; 47(4):466-71. PubMed ID: 22799028 [TBL] [Abstract][Full Text] [Related]
2. Evaluation of the anti-neuraminidase activity of the traditional Chinese medicines and determination of the anti-influenza A virus effects of the neuraminidase inhibitory TCMs in vitro and in vivo. Tian L; Wang Z; Wu H; Wang S; Wang Y; Wang Y; Xu J; Wang L; Qi F; Fang M; Yu D; Fang X J Ethnopharmacol; 2011 Sep; 137(1):534-42. PubMed ID: 21699971 [TBL] [Abstract][Full Text] [Related]
3. Screening and evaluation of commonly-used anti-influenza Chinese herbal medicines based on anti-neuraminidase activity. Han X; Zhang DK; Guo YM; Feng WW; Dong Q; Zhang CE; Zhou YF; Liu Y; Wang JB; Zhao YL; Xiao XH; Yang M Chin J Nat Med; 2016 Oct; 14(10):794-800. PubMed ID: 28236410 [TBL] [Abstract][Full Text] [Related]
4. [Evaluation of Chinese traditional patent medicines against influenza virus in vitro]. Zu M; Zhou D; Gao L; Liu AL; Du GH Yao Xue Xue Bao; 2010 Mar; 45(3):408-12. PubMed ID: 21351522 [TBL] [Abstract][Full Text] [Related]
5. Further discovery of caffeic acid derivatives as novel influenza neuraminidase inhibitors. Xie Y; Huang B; Yu K; Xu W Bioorg Med Chem; 2013 Dec; 21(24):7715-23. PubMed ID: 24262883 [TBL] [Abstract][Full Text] [Related]
6. [Design, synthesis and activity of a new type of influenza virus N1 neuraminidase inhibitors]. Yang F; Jin L; Huang NY; Chen F; Luo HJ; Chen JF Yao Xue Xue Bao; 2011 Nov; 46(11):1344-8. PubMed ID: 22260026 [TBL] [Abstract][Full Text] [Related]
7. [Isolation of the chemical constituents from Shuanghuanglian injection and their structural identification]. Lü BQ; Xing XF; Luo JB Nan Fang Yi Ke Da Xue Xue Bao; 2006 Oct; 26(10):1471-2, 1475. PubMed ID: 17062354 [TBL] [Abstract][Full Text] [Related]
9. Computational screen and experimental validation of anti-influenza effects of quercetin and chlorogenic acid from traditional Chinese medicine. Liu Z; Zhao J; Li W; Shen L; Huang S; Tang J; Duan J; Fang F; Huang Y; Chang H; Chen Z; Zhang R Sci Rep; 2016 Jan; 6():19095. PubMed ID: 26754609 [TBL] [Abstract][Full Text] [Related]
10. Design and synthesis of benzoic acid derivatives as influenza neuraminidase inhibitors using structure-based drug design. Chand P; Babu YS; Bantia S; Chu N; Cole LB; Kotian PL; Laver WG; Montgomery JA; Pathak VP; Petty SL; Shrout DP; Walsh DA; Walsh GM J Med Chem; 1997 Dec; 40(25):4030-52. PubMed ID: 9406595 [TBL] [Abstract][Full Text] [Related]
11. Advances in studies on the rupestonic acid derivatives as anti-influenza agents. Yong J; Lu C; Aisa HA Mini Rev Med Chem; 2013 Feb; 13(2):310-5. PubMed ID: 22625417 [TBL] [Abstract][Full Text] [Related]
13. [Screening bioactive compounds inhibiting influenza virus from isatidis radix by ultrafiltration mass spectrometry]. Ma LN; Zhang CE; Yan D; Tan MR; Li HB; Zhang LL; Xiong Y; Xiao XH Zhongguo Zhong Yao Za Zhi; 2014 Mar; 39(5):812-6. PubMed ID: 25204170 [TBL] [Abstract][Full Text] [Related]
14. Development of a novel method combining HPLC fingerprint and multi-ingredients quantitative analysis for quality evaluation of traditional Chinese medicine preparation. Yang DZ; An YQ; Jiang XL; Tang DQ; Gao YY; Zhao HT; Wu XW Talanta; 2011 Aug; 85(2):885-90. PubMed ID: 21726714 [TBL] [Abstract][Full Text] [Related]
15. Screening for Neuraminidase Inhibitory Activity in Traditional Chinese Medicines Used to Treat Influenza. Yang XY; Liu AL; Liu SJ; Xu XW; Huang LF Molecules; 2016 Aug; 21(9):. PubMed ID: 27618892 [TBL] [Abstract][Full Text] [Related]
16. Structure-activity relationship of flavonoids as influenza virus neuraminidase inhibitors and their in vitro anti-viral activities. Liu AL; Wang HD; Lee SM; Wang YT; Du GH Bioorg Med Chem; 2008 Aug; 16(15):7141-7. PubMed ID: 18640042 [TBL] [Abstract][Full Text] [Related]
17. Pharmacophore model of influenza neuraminidase inhibitors--a systematic review. Gong JZ; Liu Y; Xu WF Pharmazie; 2009 Oct; 64(10):627-32. PubMed ID: 19947162 [TBL] [Abstract][Full Text] [Related]
18. Neuraminidase inhibition of Dietary chlorogenic acids and derivatives - potential antivirals from dietary sources. Gamaleldin Elsadig Karar M; Matei MF; Jaiswal R; Illenberger S; Kuhnert N Food Funct; 2016 Apr; 7(4):2052-9. PubMed ID: 27010419 [TBL] [Abstract][Full Text] [Related]
19. A QSAR study on influenza neuraminidase inhibitors. Verma RP; Hansch C Bioorg Med Chem; 2006 Feb; 14(4):982-96. PubMed ID: 16213733 [TBL] [Abstract][Full Text] [Related]
20. Anti-Influenza Virus Activity and Constituents. Characterization of Paeonia delavayi Extracts. Li J; Yang X; Huang L Molecules; 2016 Aug; 21(9):. PubMed ID: 27571059 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]